Clincosm LogoSign in Get a demo

als

Showing 26 - 50 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ALS Trial in New York (rTMS)

Recruiting
  • ALS
  • rTMS
  • New York, New York
    Shara Holzberg
Mar 29, 2022

Electrical Impedance Tomography Device for Pulmonary Function

Recruiting
  • ALS
  • EIT
  • Boston, Massachusetts
  • +1 more
Mar 10, 2022

Amyotrophic Lateral Sclerosis, ALS Trial in Seoul (HYNR-CS inj, Control group)

Completed
Has Results
  • Amyotrophic Lateral Sclerosis
  • ALS
  • HYNR-CS inj
  • Control group
  • Seoul, Korea, Republic of
    Hanyang University Hospital
Mar 15, 2022

Digital Tools for Assessment of Motor Functions and Falls in ALS

Recruiting
  • ALS
  • +2 more
  • PAMSys Activity Monitoring System
  • Motor, Speech, and Handwriting Assessment
  • Hershey, Pennsylvania
    Milton S. Hershey Medical Center
Mar 7, 2022

Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig Disease Trial in United States (BHV-0223)

Completed
  • Amyotrophic Lateral Sclerosis
  • +5 more
  • Fort Lauderdale, Florida
  • +4 more
Feb 28, 2022

Amyotrophic Lateral Sclerosis, ALS Trial in Boston, Worcester (AMX0035)

Completed
  • Amyotrophic Lateral Sclerosis
  • ALS
  • Boston, Massachusetts
  • +1 more
Jan 5, 2022

Deep Phenotyping in Patients With ALS

Completed
  • ALS
  • Motor Neuron Disease
    • Phoenix, Arizona
    • +6 more
    Dec 14, 2021

    Amyotrophic Lateral Sclerosis (ALS) Families Project

    Recruiting
    • ALS
      • New York, New York
        Columbia University
      Oct 20, 2021

      A Study to Explore the Role of Gut Flora in ALS

      Recruiting
      • ALS
      • +2 more
      • No intervention
      • Ventura, California
        ProgenaBiome
      Sep 2, 2021

      ALS Trial in Paris (Electrophysiology)

      Active, not recruiting
      • ALS
      • Electrophysiology
      • Paris, France
        Hopital Pitie Salpetriere
      Aug 24, 2021

      ALS Trial in Boston (RNS60)

      Completed
      Has Results
      • ALS
      • Boston, Massachusetts
        Massachusetts General Hospital
      May 5, 2021

      Cancer, Heart Failure, Copd Trial in Winnipeg (Virtual Reality)

      Recruiting
      • Cancer
      • +3 more
      • Virtual Reality
      • Winnipeg, Manitoba, Canada
        Riverview Health Centre
      Mar 8, 2021

      Amyotrophic Lateral Sclerosis, ALS Trial in Tel Aviv (Fixed dose combination Ciprofloxacin/Celecoxib)

      Completed
      • Amyotrophic Lateral Sclerosis
      • ALS
      • Fixed dose combination Ciprofloxacin/Celecoxib
      • Tel Aviv, Israel
        Sourasky Medical Center
      Mar 2, 2021

      ALS Trial in Jerusalem (Observation)

      Recruiting
      • ALS
      • Observation
      • Jerusalem, Israel
        Hadassah Medical Organisation
      Feb 9, 2021

      ALS Trial in Japan (Perampanel, )

      Completed
      • ALS
      • Kanagawa, Japan
      • +11 more
      Jan 14, 2021

      MRI Biomarkers in ALS

      Completed
      • Amyotrophic Lateral Sclerosis
      • +2 more
      • Magnetic Resonance Imaging
      • Calgary, Alberta, Canada
      • +5 more
      Dec 4, 2020

      ALS Trial in Hershey (remote pulmonary function testing, standard pulmonary function testing)

      Completed
      Has Results
      • ALS
      • remote pulmonary function testing
      • standard pulmonary function testing
      • Hershey, Pennsylvania
        Hershey Medical Center ALS Clinic
      Jul 22, 2020

      (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products

      Terminated
      • ALS
      • +17 more
      • Registry
      • PK microsampling of blood
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Jul 28, 2020

      ALS Trial in Montpellier (phenotyping Tcells, Supplementation in vitamin D)

      Completed
      • ALS
      • phenotyping Tcells
      • Supplementation in vitamin D
      • Montpellier, France
        University Hospital of Montpellier
      May 27, 2020

      ALS, Amyotrophic Lateral Sclerosis Trial in Canada (Pimozide 2mg/day (current) or 4 mg/day (study initiation), Placebo Oral

      Unknown status
      • ALS
      • Amyotrophic Lateral Sclerosis
      • Pimozide 2mg/day (current) or 4 mg/day (study initiation)
      • Placebo Oral Tablet
      • Calgary, Alberta, Canada
      • +8 more
      May 26, 2020

      ALS Trial in Durham (Triheptanoin)

      Completed
      Has Results
      • ALS
      • Durham, North Carolina
        Duke University
      Dec 9, 2019

      ALS Trial in Kansas City (Oxaloacetic Acid)

      Unknown status
      • ALS
      • Oxaloacetic Acid
      • Kansas City, Kansas
        University of Kansas Medical Center
      Dec 17, 2019

      ALS, Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease Trial in United States (Tocilizumab, Placebo)

      Completed
      Has Results
      • ALS
      • +3 more
      • Phoenix, Arizona
      • +4 more
      Dec 16, 2019

      Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig Disease Trial (Riluzole)

      No longer available
      • Amyotrophic Lateral Sclerosis
      • +5 more
      • (no location specified)
      Jul 24, 2019

      Amyotrophic Lateral Sclerosis, ALS Trial in Sioux Falls (probiotic)

      Completed
      • Amyotrophic Lateral Sclerosis
      • ALS
      • probiotic
      • Sioux Falls, South Dakota
        Avera Medical Group Palliative Medicine Sioux Falls
      Jul 1, 2019